Biotech · Private company · Seattle, WA, US

Talus Bioscience, Inc.

Track this companyFree. Adds Talus Bioscience, Inc. to your Dealase workspace and tells you when its record changes.

Clinical trials0None registered

Pipeline programs0None found yet

Disclosed deals0None found yet

Cash runwayNot availablePrivate: no SEC financials

NIH awards4

Deployment of an AI platform to accelerate transcription factor drug developmentFiscal year 2026 · $1MNIH RePORTER 1R44TR005930-01A1 · fetched Nov 12, 2026
Activity-based regulome profiling for the discovery of covalent transcription factor inhibitorsFiscal year 2025 · $821.8KNIH RePORTER 5R44TR004349-03 · fetched Nov 12, 2026
Activity-based regulome profiling for the discovery of covalent transcription factor inhibitorsFiscal year 2024 · $821.8KNIH RePORTER 4R44TR004349-02 · fetched Nov 12, 2026
Simultaneous pharmacological profiling of oncogenic gene fusion proteins in cancerFiscal year 2024 · $1MNIH RePORTER 5R44CA268146-03 · fetched Nov 12, 2026